Literature DB >> 4281065

Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.

B Costall, R J Naylor, J C Pettit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4281065     DOI: 10.1007/bf00501147

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  40 in total

Review 1.  Drugs affecting monoamines in the basal ganglia.

Authors:  G Bartholini; A Pletscher
Journal:  Adv Biochem Psychopharmacol       Date:  1972

2.  Some aspects of the mechanism of action of various stimulant amphetamine analogues.

Authors:  J Scheel-Krüger
Journal:  Psychiatr Neurol Neurochir       Date:  1972 May-Jun

3.  Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.

Authors:  M Besson; A Cheramy; P Feltz; J Glowinski
Journal:  Brain Res       Date:  1971-09-24       Impact factor: 3.252

4.  Potassium-induced acceleration of catecholamine biosynthesis in brain slices. I. A study of the mechanism of action.

Authors:  J E Harris; R H Roth
Journal:  Mol Pharmacol       Date:  1971-11       Impact factor: 4.436

5.  Effect of spreading depression on electrical activity and dopamine turnover in the striatum of rats.

Authors:  L Pieri; G Bartholini; H H Keller; A Pletscher
Journal:  Experientia       Date:  1973-04-15

6.  Effects of spreading depression on the turnover of cerebral dopamine.

Authors:  H H Keller; G Bartholini; L Pieri; A Pletscher
Journal:  Eur J Pharmacol       Date:  1972-12       Impact factor: 4.432

7.  The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum.

Authors:  A Herz; W Zieglgänsberger
Journal:  Int J Neuropharmacol       Date:  1968-05

8.  The involvement of dopaminergic systems with the stereotyped behaviour patterns induced by methylphenidate.

Authors:  B Costall; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1974-01       Impact factor: 3.765

9.  Effects of clozapine on cerebral catecholaminergic neurone systems.

Authors:  G Bartholini; W Haefely; M Jalfre; H H Keller; A Pletscher
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

10.  Release of noradrenaline from the cat spleen by potassium.

Authors:  S M Kirpekar; A R Wakade
Journal:  J Physiol       Date:  1968-02       Impact factor: 5.182

View more
  4 in total

1.  Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum.

Authors:  E Laschka; A Herz; J Bläsig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

2.  Modulation of reward and aversion processes in the rat diencephalon by neuroleptics: differential effects of clozapine and haloperidol.

Authors:  D M Atrens; T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

3.  Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats.

Authors:  Ilaria Rosa; Davide Di Censo; Brigida Ranieri; Giuseppe Di Giovanni; Eugenio Scarnati; Marcello Alecci; Angelo Galante; Tiziana Marilena Florio
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.